Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedNo changes to core study content were detected; only minor visual/layout updates to the page were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check19 days agoNo Change Detected
- Check40 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference4%

- Check47 days agoChange DetectedCore content updated to emphasize specific chemical categories and compounds; broader/older terms removed and version bumped to v3.1.0.SummaryDifference0.9%

- Check62 days agoChange DetectedUpdated the revision tag from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new pharmaceutical solutions, while several medical topics and location details have been removed.SummaryDifference2%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.